Newsroom | 68903 results
Sorted by: Latest
-
agilon health Announces Reverse Stock Split
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL) (the “Company”), the trusted partner empowering physicians to transform health care in our communities, today announced that it will implement a reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a ratio of 1-for-25. The reverse stock split is expected to become effective on March 30, 2026, on or around 5:01 p.m. Eastern Time (“Effective Time”) and a...
-
GE HealthCare completes Intelerad acquisition – accelerating shift to cloud-first enterprise solutions to deliver precision care
CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced that it has completed the acquisition of Intelerad, a leading medical imaging software provider for the healthcare industry, for a base purchase price of $2.3 billion in cash (subject to customary adjustments). Intelerad’s technology and customer base will extend GE HealthCare’s reach into high-growth specialized clinics and ambulatory care environments, complementing the company’s strength in hospital-based imaging. These combined capabil...
-
Riassunto: Sub-Q Bionics annuncia un accordo di licenza per promuovere la cura del linfedema
STILLWATER, Minn. & TEL AVIV, Israele--(BUSINESS WIRE)--Sub‑Q Bionics, azienda produttrice di dispositivi medici che sviluppa un innovativo sistema di drenaggio impiantabile progettato per aiutare i pazienti affetti da linfedema a gestire meglio i loro sintomi, oggi ha annunciato un accordo di licenza con la Mayo Clinic. L'accordo prevede la concessione della licenza di know-how clinico in tema di chirurgia ricostruttiva e linfatica da parte della Mayo Clinic a Sub-Q Bionics. Nell'ambito di que...
-
Samenvatting: Sub-Q Bionics kondigt licentieovereenkomst aan voor verbetering van lymfoedeemzorg
STILLWATER, Minn. & TEL AVIV, Israël--(BUSINESS WIRE)--Sub-Q Bionics, een bedrijf in medische hulpmiddelen dat een innovatief implanteerbaar lymfedrainagesysteem ontwikkelt om patiënten met lymfoedeem te helpen hun symptomen beter te beheersen, heeft vandaag een licentieovereenkomst met de Mayo Clinic aangekondigd. Via deze overeenkomst heeft Sub-Q Bionics klinische knowhow van de Mayo Clinic verkregen met betrekking tot reconstructieve en lymfatische chirurgie. Als onderdeel van deze samenwerk...
-
Resumen: Sub-Q Bionics anuncia un acuerdo de licencia para mejorar la atención del linfedema
STILLWATER, Minn. & TEL AVIV, Israel--(BUSINESS WIRE)--Sub‑Q Bionics, una empresa de dispositivos médicos que desarrolla un innovador sistema implantable de drenaje linfático diseñado para ayudar a los pacientes con linfedema a controlar mejor sus síntomas, ha anunciado hoy la firma de un acuerdo de licencia con la Mayo Clinic. En virtud de este acuerdo, Sub-Q Bionics ha obtenido una licencia de la Mayo Clinic para utilizar sus conocimientos clínicos en materia de cirugía reconstructiva y linfá...
-
Sub-Q Bionics annonce un accord de licence visant à faire progresser la prise en charge du lymphœdème
STILLWATER, Minn. & TEL AVIV, Israël--(BUSINESS WIRE)--Sub-Q Bionics, la société de dispositifs médicaux développant un système innovant de drainage lymphatique implantable conçu pour aider les patients atteints de lymphœdème à mieux gérer leurs symptômes, a annoncé aujourd'hui la conclusion d'un accord de licence avec la Mayo Clinic. Dans le cadre de cet accord, Sub-Q Bionics a obtenu une licence sur le savoir-faire clinique de la Mayo Clinic en matière de chirurgie reconstructive et lymphatiq...
-
Sub-Q Bionics gibt Lizenzvereinbarung zur Weiterentwicklung der Versorgung bei Lymphödemen bekannt
STILLWATER, Minn. & TEL AVIV, Israel--(BUSINESS WIRE)--Sub-Q Bionics, ein Medizintechnikunternehmen, das ein innovatives implantierbares lymphatisches Drainagesystem entwickelt, das Menschen mit Lymphödem dabei unterstützen soll, ihre Symptome besser zu bewältigen, gab heute eine Lizenzvereinbarung mit der Mayo Clinic bekannt. Im Rahmen der Vereinbarung hat Sub-Q Bionics klinisches Fachwissen der Mayo Clinic zur rekonstruktiven Chirurgie und zur Chirurgie des Lymphsystems in Lizenz übernommen....
-
Dyno Therapeutics Launches Dyno Psi-Phi, an Agentic AI Suite for Protein Binder Design, at NVIDIA GTC 2026
WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics launches Dyno Psi-Phi, an agentic AI suite for protein binder design, at NVIDIA GTC 2026...
-
National Cleaning Week (March 22-28): New ACI Survey Reveals Where Americans Get Cleaning Advice
WASHINGTON--(BUSINESS WIRE)--As the American Cleaning Institute (ACI) celebrates National Cleaning Week (March 22–28) during its 100th anniversary, new survey data shows how Americans are getting their cleaning advice – and how often they think clean compared to their parents. With so many different sources available for today’s consumer on how to clean, a new ACI survey – conducted by Wakefield Research – discovered that 61% of Americans still primarily seek cleaning advice from family and fri...
-
Kolosis BIO® Expands Surgical Biologics Portfolio with Launch of APEXecm™
SALT LAKE CITY--(BUSINESS WIRE)--The addition of APEXecm reflects Kolosis's continued commitment to developing and commercializing best-in-class solutions for the surgical community....